Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / S&P SMLCP INDL
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
416,525
-
Shares change
-
+36,748
-
Total reported value, excl. options
-
$39,064,837
-
Value change
-
+$3,446,759
-
Number of buys
-
13
-
Number of sells
-
-5
-
Price
-
$93.8
Significant Holders of INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) as of Q1 2021
25 filings reported holding PSCI - INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL as of Q1 2021.
INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 416,525 shares
.
Largest 10 shareholders include UBS Group AG (110,367 shares), MORGAN STANLEY (103,040 shares), BANK OF AMERICA CORP /DE/ (100,443 shares), SALEM INVESTMENT COUNSELORS INC (27,675 shares), WELLS FARGO & COMPANY/MN (21,795 shares), ROYAL BANK OF CANADA (11,452 shares), Belpointe Asset Management LLC (6,781 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (5,812 shares), OPPENHEIMER & CO INC (5,064 shares), and CITADEL ADVISORS LLC (4,942 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.